NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Levi Strauss Raises Full-Year Sales & Profit Outlook After Strong Q1 Beat; Veteran CFO Harmit Singh to Retire

Levi beats expectations, raises outlook as sales grow worldwide. Strong demand for jeans and DTC sales drives profits higher.

Levi Strauss Raises Full-Year Sales & Profit Outlook After Strong Q1 Beat; Veteran CFO Harmit Singh to Retire
Credit: Sean Gallup/Getty Images
Already have an account? Sign in.
Featured/ 04/07/2026 · 4:38 PM
LEVI
/ Don’t stop at just one post.

Related↓

Levi's store
Featured/ 10/09/2025 · 5:08 PM

Levi's Raises Outlook Despite Growing Tariff Pressures

Levi Strauss raises 2025 revenue forecast to 3% growth despite facing increased tariff costs. Stock drops 6% despite beating Q3 earnings expectations and improved profit margins.

/ Subscriber only
/ Read more

Feed↓

Anthropic’s Project Glasswing Gives Cybersecurity Stocks a Big Boost
Featured/ 04/07/2026 · 5:06 PM

Anthropic’s Project Glasswing Gives Cybersecurity Stocks a Big Boost

Anthropic’s new AI helps cybersecurity firms like Palo Alto & CrowdStrike defend systems, boosting their stocks and easing investor worries.

/ Subscriber only
Insmed Discontinues Brensocatib HS Program After Phase 2b CEDAR Study Misses All Endpoints
04/07/2026 · 4:22 PM

Insmed Discontinues Brensocatib HS Program After Phase 2b CEDAR Study Misses All Endpoints

Insmed’s HS drug failed to beat placebo in a mid-stage trial, though it was safe. Development for this condition has been stopped.

/ Subscriber only
Gilead’s $5B Tubulis Deal Validates ADC Space – Bullish for Sutro Biopharma
04/07/2026 · 3:59 PM

Gilead’s $5B Tubulis Deal Validates ADC Space – Bullish for Sutro Biopharma

Leerink sees major tailwind for Sutro Biopharma and initiates coverage with $38 price target.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe